Tower Research Capital LLC TRC Purchases 6,854 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Tower Research Capital LLC TRC boosted its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 662.2% in the fourth quarter, Holdings Channel reports. The institutional investor owned 7,889 shares of the company’s stock after buying an additional 6,854 shares during the period. Tower Research Capital LLC TRC’s holdings in Aveanna Healthcare were worth $36,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Walleye Capital LLC acquired a new position in shares of Aveanna Healthcare during the fourth quarter worth $64,000. Barclays PLC raised its position in Aveanna Healthcare by 15.5% during the 4th quarter. Barclays PLC now owns 141,695 shares of the company’s stock worth $649,000 after purchasing an additional 19,006 shares during the last quarter. Sagespring Wealth Partners LLC bought a new position in Aveanna Healthcare during the 4th quarter worth $57,000. Raymond James Financial Inc. acquired a new position in Aveanna Healthcare during the 4th quarter worth about $155,000. Finally, Legal & General Group Plc grew its position in shares of Aveanna Healthcare by 577.0% in the 4th quarter. Legal & General Group Plc now owns 36,409 shares of the company’s stock valued at $166,000 after buying an additional 31,031 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the stock in a transaction that occurred on Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total transaction of $31,415.40. Following the completion of the transaction, the insider now directly owns 1,451,598 shares of the company’s stock, valued at $8,172,496.74. This represents a 0.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the firm’s stock in a transaction that occurred on Thursday, May 8th. The stock was sold at an average price of $5.84, for a total transaction of $531,796.24. Following the sale, the insider now owns 545,330 shares of the company’s stock, valued at approximately $3,184,727.20. The trade was a 14.31% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 205,512 shares of company stock valued at $1,173,001. Insiders own 7.80% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Truist Financial dropped their target price on shares of Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research report on Friday, April 11th. UBS Group upped their target price on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the stock a “sell” rating in a research note on Friday, May 9th.

Aveanna Healthcare Stock Down 0.7%

AVAH stock opened at $5.82 on Thursday. The firm has a market cap of $1.14 billion, a PE ratio of -17.12 and a beta of 2.01. The business has a 50 day moving average of $4.95 and a 200-day moving average of $4.91. Aveanna Healthcare Holdings Inc. has a 12-month low of $2.32 and a 12-month high of $6.19.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.